Related Experiment Video

Updated: Dec 13, 2025

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
09:36

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device

Published on: September 24, 2020

3.0K

[COVID-19: The Intensive Care Point-of-View]

Stephanie-Susanne Stecher, Hans Joachim Stemmler, Dennis Eichenauer

    Deutsche Medizinische Wochenschrift (1946)
    |July 31, 2020
    PubMed

    Insights

    This article outlines essential intensive care unit (ICU) management for COVID-19 patients, focusing on diagnostics, monitoring, and therapy. It emphasizes a robust hygiene concept and appropriate patient care strategies during the Corona crisis.

    Area of Science:

    • Intensive Care Medicine
    • Infectious Diseases
    • Critical Care

    Background:

    • The Corona crisis places significant demands on intensive care units (ICUs).
    • While many COVID-19 treatments are established, some aspects require clarification for ICU settings.
    • Understanding optimal care for severe COVID-19 cases is crucial.

    Purpose of the Study:

    • To detail diagnostics, monitoring, and therapy for COVID-19 patients in ICUs.
    • To highlight the importance of suitable hygiene concepts in managing COVID-19 patients.
    • To provide guidance on best practices for intensive care during the pandemic.

    Main Methods:

    • Review of current treatment modalities and best practices for COVID-19 in ICUs.
    • Emphasis on implementing a comprehensive hygiene concept, including employee training and material discharge.
    • Discussion of patient monitoring, laboratory analysis, and respiratory support strategies.

    Main Results:

    • A mandatory hygiene concept, including cohort isolation, is vital.
    • Patient monitoring in ICUs for COVID-19 is similar to other critical care patients, adapted to individual needs.
    • Laboratory analysis should consider typical COVID-19 abnormalities, including testing for fungal infections if inflammatory parameters increase.

    Conclusions:

    • Effective management of COVID-19 in ICUs requires strict adherence to hygiene protocols.
    • Careful monitoring and tailored laboratory investigations are essential for severe cases.
    • Specific ventilation strategies, such as avoiding respiratory system disconnections and considering intermittent non-invasive ventilation (NIV) post-extubation, are important for patient outcomes.

    More Related Videos

    An Educational Video Demonstration of How to Prone a Critically Ill Intubated Patient07:16

    An Educational Video Demonstration of How to Prone a Critically Ill Intubated Patient

    Published on: November 30, 2022

    4.2K
    Observational Study Protocol for Repeated Clinical Examination and Critical Care Ultrasonography Within the Simple Intensive Care Studies10:38

    Observational Study Protocol for Repeated Clinical Examination and Critical Care Ultrasonography Within the Simple Intensive Care Studies

    Published on: January 16, 2019

    20.6K

    Related Concept Videos

    Acute Respiratory Failure-I01:21

    Acute Respiratory Failure-I

    Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
    Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
    638
    Acute Respiratory Failure-III01:30

    Acute Respiratory Failure-III

    Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
    601
    Acute Respiratory Failure-II01:21

    Acute Respiratory Failure-II

    Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
    The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
    862
    Pneumonia III: Complications and Assessment01:30

    Pneumonia III: Complications and Assessment

    Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
    678
    Pneumonia IV: Management01:28

    Pneumonia IV: Management

    The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
    Bacterial Pneumonia Treatment
    For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
    643
    Acute Respiratory Failure-V01:29

    Acute Respiratory Failure-V

    The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
    Ensure that patients are monitored continuously for their response to therapy, including changes in...
    341